NCT02341053

Brief Summary

Non-ambulatory children with a neuromuscular disability such as spinal muscular atrophy (SMA) are at significant risk for poor bone health as defined by low bone mineral density (BMD) and increased propensity to fracture. Poor bone health is thought to be related, at least in part, to abnormally low levels of load experienced by the skeleton. A common physical approach for increasing bone density is to stimulate the musculoskeletal system by increasing the amount and duration of weight-bearing in the lower extremities. For non-ambulatory individuals, this takes the form of using an assisted standing device to enable the child to spend time in a standing position with some degree of weight placed on the lower limbs. Some of these physical interventions demonstrate variable improvement in BMD in children with neuromuscular conditions, and some do not. A serious limitation in the previous work in this area is a failure to objectively measure the magnitude and duration of the loading experienced by the lower extremities. Thus, a lack of change in BMD may be due to the extremities experiencing only a fraction of the body weight (due to load-sharing with the assistive device) for an inadequate duration of standing time. In order to investigate the efficacy of standing treatment for increasing BMD, the investigators will develop a simple, portable and inexpensive transducer that will measure the magnitude and time course of the load experienced by the lower extremities of individuals with SMA who use a stationary assisted standing device. The specific goal of this proposed project will be to develop, validate and establish the initial feasibility of such a measurement device.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 2, 2015

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 19, 2015

Completed
1.6 years until next milestone

Study Start

First participant enrolled

September 8, 2016

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 25, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 25, 2018

Completed
Last Updated

February 17, 2021

Status Verified

February 1, 2021

Enrollment Period

1.9 years

First QC Date

January 2, 2015

Last Update Submit

February 16, 2021

Conditions

Keywords

SMANeuromuscular disability

Outcome Measures

Primary Outcomes (1)

  • Collection of load magnitude and duration data (Use load-sensing platforms to collect load magnitude and duration during standing treatment program)

    Use load-sensing platforms to collect load magnitude and duration during standing treatment program.

    12 months

Secondary Outcomes (1)

  • Bone Mineral Density

    12 months

Study Arms (1)

Load-measuring platform

OTHER

Load-sensing platform A load-sensing platform will be placed under each foot of the subject to record the time course of load borne by each of the lower extremities during weight-bearing training in an assisted standing device. Intervention: Assisted Standing Treatment Program. Assisted standing treatment program will gradually increase their duration of standing by up to 75% after the baseline phase.

Other: Assisted Standing Treatment Program

Interventions

Assisted Standing Treatment Program - Assisted standing treatment program will be gradually increase duration of standing by up to 75% after baseline.

Load-measuring platform

Eligibility Criteria

Age3 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 3-14 years old
  • Diagnosed with Spinal Muscular Atrophy (SMA)
  • Participating in a standing program using a stationary assisted standing device.
  • Gross Motor Function Classification System (GMFCS) Level IV or V
  • Parent must be able to provide consent.

You may not qualify if:

  • \. Currently on bisphosphonates

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gillette Children's Specialty Healthcare

Saint Paul, Minnesota, 55101, United States

Location

Study Officials

  • Walter Truong, MD

    Gillette Children's Specialty Healthcare

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 2, 2015

First Posted

January 19, 2015

Study Start

September 8, 2016

Primary Completion

July 25, 2018

Study Completion

July 25, 2018

Last Updated

February 17, 2021

Record last verified: 2021-02

Locations